Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia and Laura Coates, an Associate Professor, NIH...
31 Okt 202321min
axSpA Podcast: Safety and Efficacy of Upadacitinib
Professor Hideto Kameda, Professor of Internal Medicine at Toho University in Japan, is joined by Professor Xenofon Baraliakos, Professor of Internal Medicine and Rheumatology at the Ruhr-University i...
26 Okt 202326min
CSF Author Interview: Dr. David Martin, 2023
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr. David Martin, executive medical director at Pfizer in Massachusetts, USA as they discuss his recent paper 'Biomarkers to pr...
26 Okt 202339min
Discussing Rheumatology: October 2023
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that look at the epidemiology of...
20 Okt 202311min
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer
Join Professor Peter Nash from the Griffith University in Brisbane and Dr. Andreas Kerschbaumer of the Division of Rheumatology, Department of Internal Medicine, Medical University of Vienna, Austria,...
16 Okt 202335min
CSF Author Interview: Professor Martin Bergman, 2023
Professor Peter Nash from the Griffith University in Brisbane, is joined by Professor Martin Bergman, a Clinical Associate Professor of Medicine at the Drexel University College of Medicine in Philade...
11 Okt 202327min
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, is joined by Laura Coates, an Associate Professor...
11 Okt 202331min
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Zuyderland Medical Centre and Leiden University Medical Centre in the Netherlands, is joined by Professor Hideto Kameda, Professor o...
25 Sep 202325min
